|
CCDC45 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.30479998922328E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.27870000435848E-08 |
| Normal-vs-Stage2 |
1.277590E-02 |
| Normal-vs-Stage3 |
1.120240E-02 |
| Normal-vs-Stage4 |
1.294780E-01 |
| Stage1-vs-Stage2 |
7.472600E-01 |
| Stage1-vs-Stage3 |
1.867380E-01 |
| Stage1-vs-Stage4 |
5.782200E-01 |
| Stage2-vs-Stage3 |
4.871800E-01 |
| Stage2-vs-Stage4 |
5.254600E-01 |
| Stage3-vs-Stage4 |
3.670600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.45099995854758E-09 |
| Normal-vs-AfricanAmerican |
2.27469999999341E-05 |
| Normal-vs-Asian |
2.350300E-02 |
| Caucasian-vs-AfricanAmerican |
2.878000E-01 |
| Caucasian-vs-Asian |
6.563400E-01 |
| AfricanAmerican-vs-Asian |
8.804600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.38469996474799E-09 |
| Normal-vs-Female |
1.81610000005161E-06 |
| Male-vs-Female |
4.056200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.541220E-03 |
| Normal-vs-Extreme_Weight |
6.42199999956183E-07 |
| Normal-vs-Obese |
1.67521999999698E-05 |
| Normal-vs-Extreme_Obese |
1.500840E-03 |
| Normal_Weight-vs-Extreme_Weight |
9.765400E-01 |
| Normal_Weight-vs-Obese |
7.743200E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.372200E-01 |
| Extreme_Weight-vs-Obese |
7.031800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.823000E-01 |
| Obese-vs-Extreme_Obese |
9.298800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.36390000024822E-07 |
| Normal-vs-Age(41-60Yrs) |
7.3554995427827E-10 |
| Normal-vs-Age(61-80Yrs) |
1.36529999994472E-06 |
| Normal-vs-Age(81-100Yrs) |
3.223800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.529400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.068100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.757900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.635900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.672500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.167000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.19313497654639E-13 |
| Normal-VS-Type2 PRCC |
1.380250E-01 |
| Normal-VS-KIRP CIMP |
1.749900E-02 |
| Normal-VS-Unclassified PRCC |
4.350900E-04 |
| Type1 PRCC-VS-Type2 PRCC |
7.43679999803959E-08 |
| Type1 PRCC-VS-KIRP CIMP |
9.763900E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
9.183500E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.521600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.032000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.152400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.212800E-04 |
| Normal-vs-N1 |
1.324160E-02 |
| Normal-vs-N2 |
2.606200E-01 |
| N0-vs-N1 |
3.349000E-01 |
| N0-vs-N2 |
6.145600E-01 |
| N1-vs-N2 |
4.888200E-01 |
|
|
